At a meeting of Regional Transfusion Directors it was noted that the results of the ALT multi-centre study were not expected before late spring 1989. Read more about At a meeting of Regional Transfusion Directors it was noted that the results of the ALT multi-centre study were not expected before late spring 1989.
At a meeting of the Steering Committee on Multi-Centre Study of ALT and anti-HBc Screening of Blood Donations, the study protocol was discussed in detail and it was anticipated that screening would begin on 1 September 1988. Read more about At a meeting of the Steering Committee on Multi-Centre Study of ALT and anti-HBc Screening of Blood Donations, the study protocol was discussed in detail and it was anticipated that screening would begin on 1 September 1988.
Dr Gunson shared the replies to the questionnaire on the use of surrogate screening for Non-A Non-B Hepatitis in different countries with the Advisory Committee on the Virological Safety of Blood. Read more about Dr Gunson shared the replies to the questionnaire on the use of surrogate screening for Non-A Non-B Hepatitis in different countries with the Advisory Committee on the Virological Safety of Blood.
It was agreed that a questionnaire on the use of Non-A Non-B Hepatitis surrogate screening in different countries would be circulated prior to the next European Health Committee meeting. Read more about It was agreed that a questionnaire on the use of Non-A Non-B Hepatitis surrogate screening in different countries would be circulated prior to the next European Health Committee meeting.
At a meeting of SNBTS and Haemophilia directors, Dr Forrester said that a decision on the introduction of Non-A Non-B Hepatitis screening would wait until the outcome of the multi-centre study. Dr McClelland and Professor Cash "considered the delay unjustifiable." Read more about At a meeting of SNBTS and Haemophilia directors, Dr Forrester said that a decision on the introduction of Non-A Non-B Hepatitis screening would wait until the outcome of the multi-centre study. Dr McClelland and Professor Cash "considered the delay unjustifiable."
At a SNBTS Directors' meeting it was stated that it was believed that the Birmingham RTC was about to begin routine testing of ALT and anti-HBc. Read more about At a SNBTS Directors' meeting it was stated that it was believed that the Birmingham RTC was about to begin routine testing of ALT and anti-HBc.
At a SBTS Directors' meeting it was agreed not to introduce Non-A Non-B Hepatitis surrogate screening in Scotland until it had become UK policy. Read more about At a SBTS Directors' meeting it was agreed not to introduce Non-A Non-B Hepatitis surrogate screening in Scotland until it had become UK policy.
At a SNBTS Director's Co-ordinating Group meeting it was agreed that the financial year 1988/89 should be spent in experimentation and evaluation of high ALT levels but that positive donors should not be deferred. Read more about At a SNBTS Director's Co-ordinating Group meeting it was agreed that the financial year 1988/89 should be spent in experimentation and evaluation of high ALT levels but that positive donors should not be deferred.
An article titled 'Incidence and Significance of Hepatitis B Core Antibody in a Health Blood Donor Population' was published. It was concluded that although surrogate testing introduction may eventually be unavoidable, only a controlled prospective study would provide the necessary information to determine the significance of donor anti-HBc levels in relation to PTH, especially NANB, in the United Kingdom. Read more about An article titled 'Incidence and Significance of Hepatitis B Core Antibody in a Health Blood Donor Population' was published. It was concluded that although surrogate testing introduction may eventually be unavoidable, only a controlled prospective study would provide the necessary information to determine the significance of donor anti-HBc levels in relation to PTH, especially NANB, in the United Kingdom.
A paper titled 'Post-Transfusion Non-A, Non-B Hepatitis: Significance of Raised ALT and Anti-HBc in Blood Donors' concluded that, at the time, a surrogate screening programme was not justified but further studies were required. Read more about A paper titled 'Post-Transfusion Non-A, Non-B Hepatitis: Significance of Raised ALT and Anti-HBc in Blood Donors' concluded that, at the time, a surrogate screening programme was not justified but further studies were required.